-
Mashup Score: 0Yale University | TRIALNET Type 1 Diabetes TrialNet - 4 day(s) ago
1 Long Wharf Drive New Haven, CT 06511 United States Yale is one of twenty-two Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by our Clinical Center Director and Principal Investigator, Kevan Herold, MD, the TrialNet team at Yale is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. My background and research are in translational immunology. I am interested in
Source: www.trialnet.orgCategories: General Medicine News, PediatricsTweet
-
Mashup Score: 1Type 1 diabetes community celebrates research milestone during National Diabetes Month | TRIALNET Type 1 Diabetes TrialNet - 10 day(s) ago
November 14, 2024 – More than 250,000 people have learned their risk of developing type 1 diabetes (T1D) through TrialNet screening. TrialNet and Breakthrough T1D (formerly JDRF) announced the research milestone as part of National Diabetes Month, observed each November to raise awareness about diabetes and encourage families to take action to protect their health. Research shows that people who have a relative with T1D are 15 times more likely to develop the disease than the general population. The
Source: www.trialnet.orgCategories: General Medicine News, PediatricsTweet
Yale is one of twenty-two Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research: https://t.co/jTX49GeS7l @T1D_TrialNet